132437-47-9

Upstream product

• 132360-45-3 3,4,5-tri-O-benzyl-1,2-O-cyclohexylidene-6-O-para-methoxybenzyl-D(L)-myo-inositol 
• 132360-43-1 3-O-benzyl-1,2:4,5-di-O-cyclohexylidene-6-O-para-methoxybenzyl-D(L)-myo-inositol 
• 169106-94-9 2-O-acetyl-3,4,6-tri-O-benzyl-α/β-D-mannopyranosyl fluoride 
• 23393-20-6 (+/-)-3-O-benzyl-1,2:4,5-di-O,O-cyclohexylidene-myo-inositol 
• 129214-38-6 2-O-acetyl-3,4,6-tri-O-benzyl-D-mannopyranoside 
• 125392-62-3 3,4,6-tri-O-benzyl-β-D-mannopyranose 1,2-(pent-4-enyl orthobenzoate) 
• 133162-49-9 1D-3,4,5-tri-O-benzyl-1,2-O-cyclohexylidene-myo-inositol 
• 132360-48-6 3,4,5-tri-O-benzyl-1,2-O-cyclohexylidene-6-O-(2'-O-benzoyl-3',4',6'-tri-O-benzyl-α-D-mannopyranosyl)-D(L)-myo-inositol 
• 132360-47-5 3,4,5-tri-O-benzyl-1,2-O-cyclohexylidene-6-O-(2'-O-acetyl-3',4',6'-tri-O-benzyl-α-D-mannopyranosyl)-D/L-myo-inositol 
• 132405-98-2 3,4,5-tri-O-benzyl-1,2-O-cyclohexylidene-D(L)-myo-inositol 
• 132360-44-2 3-O-benzyl-1,2-O-cyclohexylidene-6-O-para-methoxybenzyl-D(L)-myo-inositol 
• 100-39-0 benzyl bromide 
• 132360-46-4 ethyl 2-O-benzoyl-3,4,6-tri-O-benzyl-1-thio-α-D-mannopyranoside 

Downstream Products

• 312538-76-4 C₆₁H₆₅F₃O₁₃S 
• 124684-95-3 1-O-allyl-2,3,4,5-tetra-O-benzyl-6-O-(2',3',4',6'-tetra-O-benzyl-α-D-mannopyranosyl)-D-myo-inositol 
• 124684-95-3 1-O-allyl-2,3,4,5-tetra-O-benzyl-6-O-(2',3',4',6'-tetra-O-benzyl-α-D-mannopyranosyl)-L-myo-inositol 
• 132360-52-2 1-O-allyl-3,4,5-tri-O-benzyl-6-O-(2',3',4',6'-tetra-O-benzyl-α-D-mannopyranosyl)-D-myo-inositol 
• 132360-52-2 1-O-allyl-3,4,5-tri-O-benzyl-6-O-(2',3',4',6'-tetra-O-benzyl-α-D-mannopyranosyl)-L-myo-inositol 
• 132360-51-1 3,4,5-tri-O-benzyl-6-O-(2',3',4',6'-tetra-O-benzyl-α-D-mannopyranosyl)-D-myo-inositol 
• 54422-83-2 6-O-(α-D-mannopyranosyl)-D-myo-inositol 
• 132360-50-0 3,4,5-tri-O-benzyl-1,2-O-cyclohexylidene-6-O-(2',3',4',6'-tetra-O-benzyl-α-D-mannopyranosyl)-D-myo-inositol 

Relevant academic research and scientific papers

Strategies for stereocontrol at C1 or C2 in syntheses of α-glucosaminides

The C1 and C2 stereocenters of α-glucosaminides can be prepared by establishing the stereocenters in either order. For the former, a C2-azido glucosyl donor is prepared first, and the restraining effect of a 4,6-O-benzylidene ring is used to induce α-coupling. For the latter, the C1 linkage is prepared first by use of an n-pentenyl-manno-1,2-orthoester donor which ensures (a) clean α-coupling and (b) a convenient C2-ester. The C2-ester is replaced with a triflate leaving group, and nucleophilic displacement is effected by use of a hypervalent silicon azide.